Literature DB >> 25954497

Management of cirrhotic ascites.

Julie Steen Pedersen1, Flemming Bendtsen2, Søren Møller3.   

Abstract

The most common complication to chronic liver failure is ascites. The formation of ascites in the cirrhotic patient is caused by a complex chain of pathophysiological events involving portal hypertension and progressive vascular dysfunction. Since ascites formation represents a hallmark in the natural history of chronic liver failure it predicts a poor outcome with a 50% mortality rate within 3 years. Patients with ascites are at high risk of developing complications such as spontaneous bacterial peritonitis, hyponatremia and progressive renal impairment. Adequate management of cirrhotic ascites and its complications betters quality of life and increases survival. This paper summarizes the pathophysiology behind cirrhotic ascites and the diagnostic approaches, as well as outlining the current treatment options. Despite improved medical treatment of ascites, liver transplantation remains the ultimate treatment and early referral of the patient to a highly specialized hepatology unit should always be considered.

Entities:  

Keywords:  arterial vasodilation; ascites; cirrhosis; hepatorenal syndrome; portal hypertension; spontaneous bacterial peritonitis

Year:  2015        PMID: 25954497      PMCID: PMC4416972          DOI: 10.1177/2040622315580069

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN: 2040-6223            Impact factor:   5.091


  101 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.

Authors:  P Deltenre; P Mathurin; S Dharancy; R Moreau; P Bulois; J Henrion; F R Pruvot; O Ernst; J C Paris; D Lebrec
Journal:  Liver Int       Date:  2005-04       Impact factor: 5.828

3.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

Review 4.  Pathological bacterial translocation in liver cirrhosis.

Authors:  Reiner Wiest; Melissa Lawson; Markus Geuking
Journal:  J Hepatol       Date:  2013-08-28       Impact factor: 25.083

5.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

6.  Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.

Authors:  Paolo Angeli; Ezequiel Rodríguez; Salvatore Piano; Xavier Ariza; Filippo Morando; Elsa Solà; Antonietta Romano; Elisabet García; Marco Pavesi; Alessandro Risso; Alexander Gerbes; Chris Willars; Mauro Bernardi; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2014-10-13       Impact factor: 23.059

7.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

Review 8.  Hepatorenal syndrome.

Authors:  Pere Ginès; Mónica Guevara; Vicente Arroyo; Juan Rodés
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

9.  Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.

Authors:  R Solà; M C Vila; M Andreu; M I Oliver; S Coll; J Gana; S Ledesma; P Ginès; W Jiménez; V Arroyo
Journal:  J Hepatol       Date:  1994-02       Impact factor: 25.083

Review 10.  Update on ascites and hepatorenal syndrome.

Authors:  P Gentilini; F Vizzutti; A Gentilini; M Zipoli; M Foschi; R G Romanelli
Journal:  Dig Liver Dis       Date:  2002-08       Impact factor: 4.088

View more
  14 in total

1.  Comparing the Effects of Hydroxyethyl Starch and Albumin in Cirrhotic Patients with Tense Ascites; a Randomized Clinical Trial.

Authors:  Alireza Abootalebi; Sepideh Khazaei; Mohammad Minakari; Mohammad Nasr-Isfahani; Mehrdad Esmailian; Farhad Heydari
Journal:  Adv J Emerg Med       Date:  2017-10-12

2.  Laparoscopic versus open ventral hernia repair in patients with chronic liver disease.

Authors:  Yen-Yi Juo; Matthew Skancke; Jeremy Holzmacher; Richard L Amdur; Paul P Lin; Khashayar Vaziri
Journal:  Surg Endosc       Date:  2016-06-22       Impact factor: 4.584

Review 3.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

4.  Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.

Authors:  Masayuki Miyazaki; Masayoshi Yada; Kosuke Tanaka; Takeshi Senjyu; Takeshi Goya; Kenta Motomura; Motoyuki Kohjima; Masaki Kato; Akihide Masumoto; Kazuhiro Kotoh
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

5.  Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis.

Authors:  Ran Wang; Xingshun Qi; Xiaozhong Guo
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

6.  Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: A prospective study.

Authors:  Ulrich Mayr; Eugen Karsten; Tobias Lahmer; Sebastian Rasch; Philipp Thies; Benedikt Henschel; Gerrit Fischer; Roland M Schmid; Wolfgang Huber
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

Review 7.  Review: Mechanotransduction in ovarian cancer: Shearing into the unknown.

Authors:  Caymen Novak; Eric Horst; Geeta Mehta
Journal:  APL Bioeng       Date:  2018-06-07

Review 8.  Current approaches to the management of patients with cirrhotic ascites.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

Review 9.  Hepatic hydrothorax: An update and review of the literature.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev
Journal:  World J Hepatol       Date:  2017-11-08

10.  A single-case study of management of Jalodara (ascites).

Authors:  Shital Gopalbhai Bhagiya; Ram B Shukla; Nayan P Joshi; Anup B Thakar
Journal:  Ayu       Date:  2017 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.